Tozorakimab - CAS 2376858-66-9

Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting IL-33. It inhibits IL-33 signaling through ST2 and RAGE/EGFR, reduces inflammation and epithelial dysfunction, and can be used to study chronic obstructive pulmonary disease.

Interleukin, Others

Others, Immunology/Inflammation

2376783

0.998

-20°C

Ice Packs

Inhibitory Antibodies